Serum Institute & Bharat Biotech's Covid vaccines, currently authorised only for emergency use in India, were granted approval by DCGI on certain conditions, official source said.
Bharat Biotech said a study at Emory University demonstrated that people who got a Covaxin booster, 6 months after the two doses, witnessed neutralising of the two Covid variants.
Study, which is yet to be peer-reviewed, was published on preprint portal medRxiv Saturday. It was conducted by Bharat Biotech and ICMR, which co-developed the vaccine.
First-of-its-kind study in India looked at reinfection rates among 4,978 healthcare workers, who had tested positive for Covid between 3 March 2020 and 18 June 2021.
Trial on third Covaxin shot ongoing, results to be out soon, says Bharat Biotech. ICMR officials say 9-month interval based on studies that show antibodies last 6-13 months.
Only Covaxin will be used for vaccinating an estimated 7.4 crore 15-18-year-olds, so finding a slot for the first shot of the indigenous vaccine could get more difficult.
PM Modi had announced on 25 December that adolescents above the age of 15 will be able to take their vaccines from 3 January. The campaign began Monday.
With the fictitious Rajni from rural India as its guiding light, iSPIRT has been using internet & software to change structure of country’s economy, with aim to improve quality of life.
These registrations pertain to the Indian Air Force's Agniveer Vayu programme. The online portal for the first phase was opened at 10 am Friday, and will close on 5 July.
Modi govt's biggest flaw has been its disinclination to accept limitations of electoral majorities. This ruined land acquisition and farm reform, stalled labour codes.